Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
   
Ask the Experts About

Choosing Your MedsChoosing Your Meds
          
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Complera vs. Stribild
Sep 30, 2012

Hi, i have been taking Complera for two months and my viral load has gone from 174,000 to 224. My CD4 has also increased from 284 to 328 . I have recently spoken with my doctor about the new drug Quad (now called Stribild). I have done some research but as it is so new I can't find much info regarding whether I should stick with Complera or go with Stribild? Any input would be appreciated.

Response from Dr. McGowan

It seems to me that you have had a good response to Complera in the two months you have been taking it so switching to another regimen seems premature. You would need to make sure that the viral load continues to decrease to undetectable levels while on Complera. If one is considering a switch to Stribild, you should discuss this with your doctor especially since there are potential drug-drug interactions that may need to be reviewed.



Previous
AIDS and CMV retinitis
Next
Meningococcal Disease Outbreak

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement